Top Markets
Coin of the day
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
शेयरों में रैंक #13828
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
शेयर मूल्य
$4.36
मार्केट कैप
$457.32M
बदलाव (1 दिन)
0.69%
बदलाव (1 वर्ष)
289.29%
देश
US
व्यापार Relmada Therapeutics, Inc. (RLMD)

श्रेणी

Relmada Therapeutics, Inc. (RLMD) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $4.68 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $11.43 (2014-06-01 को)
Relmada Therapeutics, Inc. के स्टॉक मूल्य का इतिहास 2014 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 10.22%
2025 860.47%
2024 -36.35%
2023 -17.50%
2022 -78.37%
2021 -41.31%
2020 -14.84%
2019 756.21%
2018 52.34%
2017 -6.63%
2016 -71.17%
2015 -80.90%
2014 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.01 -13.08%
AU
$138.80 476.17%
US
$749.90 5.87%
CH